Loading…

Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation

Clostridium difficile infection (CDI) represents one of the most common healthcare-associated infections. Due to increasing numbers of recurrences and therapy failures, CDI has become a major disease burden. Studies have shown that fecal microbiota transplantation (FMT) can both be a safe and highly...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in gastroenterology 2018-01, Vol.12 (1), p.76-84
Main Authors: Schneider, Kai Markus, Wirtz, Theresa H., Kroy, Daniela, Albers, Stefanie, Neumann, Ulf Peter, Strowig, Till, Sellge, Gernot, Trautwein, Christian
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823
cites cdi_FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823
container_end_page 84
container_issue 1
container_start_page 76
container_title Case reports in gastroenterology
container_volume 12
creator Schneider, Kai Markus
Wirtz, Theresa H.
Kroy, Daniela
Albers, Stefanie
Neumann, Ulf Peter
Strowig, Till
Sellge, Gernot
Trautwein, Christian
description Clostridium difficile infection (CDI) represents one of the most common healthcare-associated infections. Due to increasing numbers of recurrences and therapy failures, CDI has become a major disease burden. Studies have shown that fecal microbiota transplantation (FMT) can both be a safe and highly efficacious therapy for patients with therapy-refractory CDI. However, patients undergoing solid organ transplantation are at high risk for CDI due to long-term immunosuppression, previous antibiotic therapy, and proton pump inhibitor use. Additionally, these patients may be especially prone to adverse events related to FMT. Here, we report a successful FMT in a patient with severe therapy-refractory CDI after liver transplantation.
doi_str_mv 10.1159/000481937
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_proquest_journals_2117200807</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1657f22481b548d48c4b40b9643e48a8</doaj_id><sourcerecordid>2020898528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823</originalsourceid><addsrcrecordid>eNptksFu1DAQhiMEoqVw4I6QpV7gsDB2nMS-IKEVLSstAtFytibOeOuSjbd2UsQ78NB4u2XVVpw8mvnmn9HvKYqXHN5xXun3ACAV12XzqDjkdS1mUJf88Z34oHiW0iVALUXJnxYHQtdQawmHxZ-zyVpKyU09OyGLPfvibQytDyOy84hD2vQ4jDj6MDA_MGTfckzDyH758YKd0TVFYvOw3vTe4kgdm_chjdF3flqzzjvnre-JLQZH9kYE3UiRLX1ufDjgefHEYZ_oxe17VPw4-XQ-_zxbfj1dzD8uZ7YCaGZIVadA8boiqyuh0WnBJVknheQOWy1QCeAcGtDWoSwlyZxrOmm5q5Qoj4rFTrcLeGk20a8x_jYBvblJhLgyGEdvezJ5SOOEyPa2lVSdVFa2Elpdy5KkQpW1Puy0NlO7ps5mayL290TvVwZ_YVbh2lSq1lXTZIE3twIxXE2URrP2yVKfXaEwJSNAgNKqEttZxw_QyzDFIVtlBOeNAFCwFXy7o_I_phTJ7ZfhYLb3Yvb3ktnXd7ffk_8OJAOvdsBPjCuKe2Dff_zf8vz76Y4wm86VfwHt99Dl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2117200807</pqid></control><display><type>article</type><title>Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation</title><source>NCBI_PubMed Central(免费)</source><source>Karger Open Access</source><creator>Schneider, Kai Markus ; Wirtz, Theresa H. ; Kroy, Daniela ; Albers, Stefanie ; Neumann, Ulf Peter ; Strowig, Till ; Sellge, Gernot ; Trautwein, Christian</creator><creatorcontrib>Schneider, Kai Markus ; Wirtz, Theresa H. ; Kroy, Daniela ; Albers, Stefanie ; Neumann, Ulf Peter ; Strowig, Till ; Sellge, Gernot ; Trautwein, Christian</creatorcontrib><description>Clostridium difficile infection (CDI) represents one of the most common healthcare-associated infections. Due to increasing numbers of recurrences and therapy failures, CDI has become a major disease burden. Studies have shown that fecal microbiota transplantation (FMT) can both be a safe and highly efficacious therapy for patients with therapy-refractory CDI. However, patients undergoing solid organ transplantation are at high risk for CDI due to long-term immunosuppression, previous antibiotic therapy, and proton pump inhibitor use. Additionally, these patients may be especially prone to adverse events related to FMT. Here, we report a successful FMT in a patient with severe therapy-refractory CDI after liver transplantation.</description><identifier>ISSN: 1662-0631</identifier><identifier>EISSN: 1662-0631</identifier><identifier>DOI: 10.1159/000481937</identifier><identifier>PMID: 29606940</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Abdomen ; Antibiotics ; Bacterial infections ; Case and Review ; Case reports ; Clostridium difficile infection ; Diarrhea ; Fecal microbiota transplantation ; Feces ; Infections ; Infectious diseases ; Inflammatory bowel disease ; Liver ; Liver transplantation ; Liver transplants ; Microbiota ; Patients ; Pseudomembranous colitis ; Transplants &amp; implants ; Ultrasonic imaging</subject><ispartof>Case reports in gastroenterology, 2018-01, Vol.12 (1), p.76-84</ispartof><rights>2018 The Author(s). Published by S. Karger AG, Basel</rights><rights>Copyright © 2018 by S. Karger AG, Basel 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823</citedby><cites>FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869577/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869577/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27635,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29606940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schneider, Kai Markus</creatorcontrib><creatorcontrib>Wirtz, Theresa H.</creatorcontrib><creatorcontrib>Kroy, Daniela</creatorcontrib><creatorcontrib>Albers, Stefanie</creatorcontrib><creatorcontrib>Neumann, Ulf Peter</creatorcontrib><creatorcontrib>Strowig, Till</creatorcontrib><creatorcontrib>Sellge, Gernot</creatorcontrib><creatorcontrib>Trautwein, Christian</creatorcontrib><title>Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation</title><title>Case reports in gastroenterology</title><addtitle>Case Rep Gastroenterol</addtitle><description>Clostridium difficile infection (CDI) represents one of the most common healthcare-associated infections. Due to increasing numbers of recurrences and therapy failures, CDI has become a major disease burden. Studies have shown that fecal microbiota transplantation (FMT) can both be a safe and highly efficacious therapy for patients with therapy-refractory CDI. However, patients undergoing solid organ transplantation are at high risk for CDI due to long-term immunosuppression, previous antibiotic therapy, and proton pump inhibitor use. Additionally, these patients may be especially prone to adverse events related to FMT. Here, we report a successful FMT in a patient with severe therapy-refractory CDI after liver transplantation.</description><subject>Abdomen</subject><subject>Antibiotics</subject><subject>Bacterial infections</subject><subject>Case and Review</subject><subject>Case reports</subject><subject>Clostridium difficile infection</subject><subject>Diarrhea</subject><subject>Fecal microbiota transplantation</subject><subject>Feces</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Inflammatory bowel disease</subject><subject>Liver</subject><subject>Liver transplantation</subject><subject>Liver transplants</subject><subject>Microbiota</subject><subject>Patients</subject><subject>Pseudomembranous colitis</subject><subject>Transplants &amp; implants</subject><subject>Ultrasonic imaging</subject><issn>1662-0631</issn><issn>1662-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>DOA</sourceid><recordid>eNptksFu1DAQhiMEoqVw4I6QpV7gsDB2nMS-IKEVLSstAtFytibOeOuSjbd2UsQ78NB4u2XVVpw8mvnmn9HvKYqXHN5xXun3ACAV12XzqDjkdS1mUJf88Z34oHiW0iVALUXJnxYHQtdQawmHxZ-zyVpKyU09OyGLPfvibQytDyOy84hD2vQ4jDj6MDA_MGTfckzDyH758YKd0TVFYvOw3vTe4kgdm_chjdF3flqzzjvnre-JLQZH9kYE3UiRLX1ufDjgefHEYZ_oxe17VPw4-XQ-_zxbfj1dzD8uZ7YCaGZIVadA8boiqyuh0WnBJVknheQOWy1QCeAcGtDWoSwlyZxrOmm5q5Qoj4rFTrcLeGk20a8x_jYBvblJhLgyGEdvezJ5SOOEyPa2lVSdVFa2Elpdy5KkQpW1Puy0NlO7ps5mayL290TvVwZ_YVbh2lSq1lXTZIE3twIxXE2URrP2yVKfXaEwJSNAgNKqEttZxw_QyzDFIVtlBOeNAFCwFXy7o_I_phTJ7ZfhYLb3Yvb3ktnXd7ffk_8OJAOvdsBPjCuKe2Dff_zf8vz76Y4wm86VfwHt99Dl</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Schneider, Kai Markus</creator><creator>Wirtz, Theresa H.</creator><creator>Kroy, Daniela</creator><creator>Albers, Stefanie</creator><creator>Neumann, Ulf Peter</creator><creator>Strowig, Till</creator><creator>Sellge, Gernot</creator><creator>Trautwein, Christian</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>201801</creationdate><title>Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation</title><author>Schneider, Kai Markus ; Wirtz, Theresa H. ; Kroy, Daniela ; Albers, Stefanie ; Neumann, Ulf Peter ; Strowig, Till ; Sellge, Gernot ; Trautwein, Christian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Abdomen</topic><topic>Antibiotics</topic><topic>Bacterial infections</topic><topic>Case and Review</topic><topic>Case reports</topic><topic>Clostridium difficile infection</topic><topic>Diarrhea</topic><topic>Fecal microbiota transplantation</topic><topic>Feces</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Inflammatory bowel disease</topic><topic>Liver</topic><topic>Liver transplantation</topic><topic>Liver transplants</topic><topic>Microbiota</topic><topic>Patients</topic><topic>Pseudomembranous colitis</topic><topic>Transplants &amp; implants</topic><topic>Ultrasonic imaging</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schneider, Kai Markus</creatorcontrib><creatorcontrib>Wirtz, Theresa H.</creatorcontrib><creatorcontrib>Kroy, Daniela</creatorcontrib><creatorcontrib>Albers, Stefanie</creatorcontrib><creatorcontrib>Neumann, Ulf Peter</creatorcontrib><creatorcontrib>Strowig, Till</creatorcontrib><creatorcontrib>Sellge, Gernot</creatorcontrib><creatorcontrib>Trautwein, Christian</creatorcontrib><collection>Karger Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Case reports in gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schneider, Kai Markus</au><au>Wirtz, Theresa H.</au><au>Kroy, Daniela</au><au>Albers, Stefanie</au><au>Neumann, Ulf Peter</au><au>Strowig, Till</au><au>Sellge, Gernot</au><au>Trautwein, Christian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation</atitle><jtitle>Case reports in gastroenterology</jtitle><addtitle>Case Rep Gastroenterol</addtitle><date>2018-01</date><risdate>2018</risdate><volume>12</volume><issue>1</issue><spage>76</spage><epage>84</epage><pages>76-84</pages><issn>1662-0631</issn><eissn>1662-0631</eissn><abstract>Clostridium difficile infection (CDI) represents one of the most common healthcare-associated infections. Due to increasing numbers of recurrences and therapy failures, CDI has become a major disease burden. Studies have shown that fecal microbiota transplantation (FMT) can both be a safe and highly efficacious therapy for patients with therapy-refractory CDI. However, patients undergoing solid organ transplantation are at high risk for CDI due to long-term immunosuppression, previous antibiotic therapy, and proton pump inhibitor use. Additionally, these patients may be especially prone to adverse events related to FMT. Here, we report a successful FMT in a patient with severe therapy-refractory CDI after liver transplantation.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>29606940</pmid><doi>10.1159/000481937</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1662-0631
ispartof Case reports in gastroenterology, 2018-01, Vol.12 (1), p.76-84
issn 1662-0631
1662-0631
language eng
recordid cdi_proquest_journals_2117200807
source NCBI_PubMed Central(免费); Karger Open Access
subjects Abdomen
Antibiotics
Bacterial infections
Case and Review
Case reports
Clostridium difficile infection
Diarrhea
Fecal microbiota transplantation
Feces
Infections
Infectious diseases
Inflammatory bowel disease
Liver
Liver transplantation
Liver transplants
Microbiota
Patients
Pseudomembranous colitis
Transplants & implants
Ultrasonic imaging
title Successful Fecal Microbiota Transplantation in a Patient with Severe Complicated Clostridium difficile Infection after Liver Transplantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A39%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20Fecal%20Microbiota%20Transplantation%20in%20a%20Patient%20with%20Severe%20Complicated%20Clostridium%20difficile%20Infection%20after%20Liver%20Transplantation&rft.jtitle=Case%20reports%20in%20gastroenterology&rft.au=Schneider,%20Kai%C2%A0Markus&rft.date=2018-01&rft.volume=12&rft.issue=1&rft.spage=76&rft.epage=84&rft.pages=76-84&rft.issn=1662-0631&rft.eissn=1662-0631&rft_id=info:doi/10.1159/000481937&rft_dat=%3Cproquest_doaj_%3E2020898528%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5007-ae5d808165ec9529af9214ecf4241fab92a820110709cfa434e492a7d4c1f5823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2117200807&rft_id=info:pmid/29606940&rfr_iscdi=true